- Home
- RVMD vs SNX Comparison
RVMD vs SNX Comparison
Compare RVMD & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | SNX |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 18.3B |
| IPO Year | N/A | 2003 |
Fundamental Metrics
Financial Performance| Metric | RVMD | SNX |
|---|---|---|
| Price | $146.92 | $235.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 10 |
| Target Price | $140.84 | ★ $198.70 |
| AVG Volume (30 Days) | ★ 3.7M | 728.9K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | N/A | ★ 25.16 |
| EPS | N/A | ★ 4.04 |
| Revenue | N/A | ★ $20,053,764,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | $533.02 | $5.69 |
| P/E Ratio | ★ N/A | $58.01 |
| Revenue Growth | N/A | ★ 17.65 |
| 52 Week Low | $34.00 | $115.85 |
| 52 Week High | $155.70 | $235.36 |
Technical Indicators
Market Signals| Indicator | RVMD | SNX |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 83.02 |
| Support Level | $93.39 | $146.57 |
| Resistance Level | $152.85 | N/A |
| Average True Range (ATR) | 7.19 | 5.77 |
| MACD | -0.47 | -0.30 |
| Stochastic Oscillator | 61.79 | 96.93 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.